In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Integra LifeSciences nets $303.8mm through public offering

Executive Summary

Integra LifeSciences Holdings Corp. (instruments and devices for reconstructive and general surgery, neurosurgery, and orthopedic extremity surgery) netted $303.8mm through a public offering of 5.25mm common shares at $58.50. The company will use the proceeds to reduce revolving borrowings under an outstanding senior credit facility.
Deal Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
    • Implantable Devices
    • Monitoring Equipment & Devices
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies

Advertisement
UsernamePublicRestriction

Register